Analysis of the HNF4α gene in Caucasian Type II diabetic nephropathic patients

Diabetologia

Volumn 43, Issue 3, 2000, Pages 364-372

  Price, J A ^a   Fossey, S C ^a   Sale, M M ^a   Brewer, C S ^a   Freedman, B I ^a   Wuerth, J P ^b   Bowden, D W ^a  

^a WAKE FOREST SCHOOL OF MEDICINE   (United States)

^b Alteon Inc   (United States)

Author keywords

Gene expression; Hepatocyte nuclear factor; Promoter; Transcription factors; Type II diabetes

Indexed keywords

NUCLEAR FACTOR I; TRANSCRIPTION FACTOR;

ARTICLE; CAUCASIAN; CONTROLLED STUDY; DIABETOGENESIS; DISEASE PREDISPOSITION; ELECTROPHORETIC MOBILITY; EXON; GENE DELETION; GENE EXPRESSION; GENE MUTATION; GENETIC ANALYSIS; HUMAN; KIDNEY DISEASE; MAJOR CLINICAL STUDY; NON INSULIN DEPENDENT DIABETES MELLITUS; PRIORITY JOURNAL; PROMOTER REGION;

EID: 0034061223     PISSN: 0012186X     EISSN: None     Source Type: Journal    
DOI: 10.1007/s001250050055     Document Type: Article

References (48)

1. 1. King H, Rewers M, WHO Ad Hoc Diabetes Reporting Group (1993) Global estimates for prevalence of diabetes mellitus and impaired glucose tolerance in adults. Diabetes Care 16: 157-177
2. 2. Hanis CL, Boerwinkle E, Chakraborty R et al. (1996) A genome-wide search for human non-insulin dependent (type 2) diabetes genes reveals a major susceptibility locus on chromosome 2. Nat Genet 13: 161-166
3. 3. Mahtani MM, Widen E, Lehto M et al. (1996) Mapping of a gene for type 2 diabetes mellitus associated with an insulin secretion defect by genome scan in Finnish families. Nat Genet 14: 90-94
4. 4. Fajans SS (1990) Scope and heterogeneous nature of MODY. Diabetes Care 13: 49-64
5. 5. Herman WH, Fajans SS, Ortiz FJ et al. (1994) Abnormal insulin secretion, not insulin resistance, is the genetic or primary defect of MODY in the RW Pedigree. Diabetes 43: 40-46
6. 6. Yamagata K, Furuta H, Oda N et al. (1996) Mutations in the hepatocyte nuclear factor-4α gene in maturity-onset diabetes of the young (MODY1). Nature 384: 458-460
7. 7. Miller SP, Anand GR, Karschnia EJ, Bell GI, LaPorte DC, Lange AJ (1999) Characterization of glucokinase mutations associated with maturity-onset diabetes of the young type 2 (MODY2): different glucokinase defects lead to a common phenotype. Diabetes 48: 1645-1651
8. 8. Yamagata K, Oda N, Kaisaki PJ et al. (1996) Mutations in the hepatocyte nuclear factor-1α gene in maturity-onset diabetes of the young (MODY3). Nature 384: 455-458
9. 9. Stoffers DA, Ferrer J, Clarke WL, Habener JF (1997) Early-onset type-II diabetes mellitus (MODY4) linked to IPF1. Nat Genet 17: 138-139
10. 10. Horikawa Y, Iwasaki N, Hara M et al. (1997) Mutation in hepatocyte nuclear factor-1 beta gene (TCF2) associated with MODY. Nat Genet 17: 384-385
11. 11. Stöffel M, Duncan SA (1997) The maturity-onset diabetes of the young (MODY1) transcription factor HNF4α regulates expression of genes required for glucose transport and metabolism. Proc Natl Acad Sci USA 94: 13209-13214
12. 12. Sladek FM (1994) Hepatocyte nuclear factor 4 (HNF4). In: Tronche F, Yaniv M (eds) Liver Gene Expression. Landes, Austin, pp 207-230
13. 13. Hattersley AT (1998) Maturity-onset diabetes of the young: clinical heterogeneity explained by genetic heterogeneity. Diabet Med 15: 15-24
14. 14. Vaxillaire M, Rouard M, Yamagata K et al. (1997) Identification of nine novel mutations in the hepatocyte nuclear factor 1 alpha gene associated with maturity-onset diabetes of the young (MODY3). Hum Mol Genet 6: 583-586
15. 15. Kaisaki PJ, Menzel S, Lindner T et al. (1997) Mutations in the hepatocyte nuclear factor-1-alpha gene in MODY and early-onset NIDDM: evidence for a mutational hotspot in exon 4. Diabetes 46: 528-535
16. 16. Hansen T, Eiberg H, Rouard M et al. (1997) Novel MODY3 mutations in the hepatocyte nuclear factor-1-alpha gene: evidence for a hyperexcitability of pancreatic beta-cells to intravenous secretagogues in a glucose tolerant carrier of a P447L mutation. Diabetes 46: 726-730
17. 17. Gragnoli C, Lindner T, Cockburn BN, Kaisaki PJ, Gragnoli F, Marozzi G, Bell GI (1997) Maturity-onset diabetes of the young due to a mutation in the hepatocyte nuclear factor-4-alpha binding site in the promoter of the hepatocyte nuclear factor-1-alpha gene. Diabetes 46: 1648-1651
18. 18. Frayling TM, Bulman MP, Appleton M, Hattersley AT, Ellard S (1997) A rapid screening method for hepatocyte nuclear factor 1 alpha frameshift mutations; prevalence in maturity-onset diabetes of the young and late-onset non-insulin dependent diabetes. Hum Genet 101: 351-354
19. 19. Frayling TM, Bulman MP, Ellard S et al.(1997) Mutations in the hepatocyte nuclear factor-1-alpha gene are a common cause of maturity-onset diabetes of the young in the U.K. Diabetes 46: 720-725
20. 20. Lindner T, Gragnoli C, Furuta H et al. (1997) Hepatic function in a family with a nonsense mutation (R154X) in the hepatocyte nuclear factor-4-alpha/MODY1 gene. J Clin Invest 100: 1400-1405
21. 21. Furuta H, Iwasaki N, Oda N et al. (1997) Organization and partial sequence of the hepatocyte nuclear factor-4α/ MODY1 gene and identification of a missense mutation, R127W, in a Japanese family with MODY. Diabetes 46: 1652-1657
22. 22. Hani EH, Suaud L, Boutin P et al. (1998) A missense mutation in hepatocyte nuclear factor-4α resulting in a reduced transactivation activity, in human late-onset non-insulin-dependent diabetes mellitus. J Clin Invest 101: 521-526
23. 23. Bulman MP, Dronsfield MJ, Frayling T et al. (1997) A missense mutation in the hepatocyte nuclear factor 4 alpha gene in a UK pedigree with maturity-onset diabetes of the young. Diabetologia 40: 859-862
24. 24. Moller AM, Dalgaard LT, Ambye L et al. (1999) A novel Phe75fsdelT mutation in the hepatocyte nuclear factor-4alpha gene in a Danish pedigree with maturity onset diabetes of the young. J Clin Endocrinol Metab 84: 367-369
25. 25. Malecki MT, Yang Y, Antonellis A et al. (1999) Identification of new mutations in the hepatocyte nuclear factor 4alpha gene among families with early onset type 2 diabetes mellitus. Diabet Med 16: 193-200
26. 26. Bowden DW, Sale M, Howard TD et al. (1997) Linkage of genetic markers on human chromosomes 20 and 12 to NIDDM in Caucasian sib pairs with a history of diabetic nephropathy. Diabetes 46: 882-886
27. 27. Ji L, Malecki M, Warram JH, Yang Y, Rich SS, Krolewski AS (1997) New susceptibility locus for NIDDM is localized to human chromosome 20q. Diabetes 46: 876-881
28. 28. Zouali H, Hani EH, Philippi A et al. (1997) A susceptibility locus for early-onset non-insulin dependent (type 2) diabetes mellitus maps to chromosome 20q, proximal to the phophoenolpyruvate carboxykinase gene. Hum Mol Genet 6: 1401-1408
29. 29. Ghosh S, Watanabe RM, Hauser E et al. (1999) Type 2 diabetes: evidence for linkage on chromosome 20 in 716 Finnish affected sibpairs. Proc Natl Acad Sci USA 96: 2198-2203
30. 30. Price JA, Brewer CS, Howard TD et al. (1997) Construction of a physical map of chromosome 20q12-13.1 and linkage disequilibrium analysis in diabetic nephropathy patients. Am J Hum Genet 61[Suppl]:A241 (Abstract)
31. 31. Bench AJ, Aldred MA, Humphray SJ et al. (1998) A detailed physical and transcriptional map of the region of chromosome 20 that is deleted in myeloproliferative disorders and refinement of the common deleted region. Genomics 49: 351-362
32. 32. Stoffel M, Le Beau MM, Espinosa R et al. (1996) A yeast artificial chromosome-based map of the region of chromosome 20 containing the diabetes-susceptibility gene, MODY1, and a myeloid leukemia related gene. Proc Natl Acad Sci USA 93: 3937-3941
33. 33. Price JA, Brewer CS, Howard TD et al. (1999) A physical map of the 20q12-13.1 region associated with Type 2 diabetes. Genomics 62: 208-215
34. 34. Zhang J, Madden TL (1997) PowerBLAST: a new network BLAST application for interactive or automated sequence analysis and annotation. Genome Res 7: 649-656
35. 35. Dawson PA, Hofmann SL, van der Westhuyzen DR, Sudhof TC, Brown MS, Goldstein JL (1988) Sterol-dependent repression of low density lipoprotein receptor promoter mediated by 16-base pair sequence adjacent to binding site for the transcription factor Sp1. J Biol Chem 263: 3372-3379
36. 36. Lee F, Hall CV, Ringold GM, Dobson DE, Luh J, Jacob PE (1984) Functional analysis of the steroid hormone control region of mouse mammary tumor virus. Nucleic Acids Res 12: 4191-4206
37. 37. Locker J, Buzard G (1990) A dictionary of transcription control sequences. DNA Seq 1: 3-11
38. 38. Malecki MT, Antonellis A, Casey P et al. (1998) Exclusion of the hepatocyte nuclear factor 4α as a candidate gene for late-onset NIDDM linked with chromosome 20q. Diabetes 46: 970-972
39. 39. Moller AM, Urhammer SA, Dalgaard LT et al. (1997) Studies of the genetic variability of the coding region of the hepatocyte nuclear factor-4α in Caucasians with maturity onset NIDDM. Diabetologia 40: 980-983
40. 40. Kritis AA, Argyrokastritis A, Moschonas NK et al. (1996) Isolation and characterization of a third isoform of human hepatocyte nuclear factor 4. Gene 173: 275-280
41. 41. Kagonaga JT, Jones KA, Tijan R (1986) Promoter-specific activation of RNA polymerase II transcription by Sp1. Trends Biochem Sci 11: 20-23
42. 42. Lin X, Wang Z, Gu L, Deuel TF (1992) Functional analysis of the human platelet-derived growth factor A-chain promoter region. J Biol Chem 267: 25614-25619
43. 43. Araki E, Murakami T, Shirotani T et al. (1991) A cluster of four Sp1 binding sites required for efficient expression of the human insulin receptor gene. J Biol Chem 266: 3944-3948
44. 44. Zutter MM, Ryan EE, Painter AD (1997) Binding of phosphorylated Sp1 protein to tandem Sp1 binding sites regulates α2 integrin gene promoter activity. Blood 90: 678-689
45. 45. Lania L, Majello B, De Luca P (1997) Transcriptional regulation by the Sp family proteins. Int J Biochem Cell Biol 29: 1313-1323
46. 46. Sladek FM, Dallas-Yang Q, Nepomuceno L (1998) MODY1 mutation Q268X in hepatocyte nuclear factor 4a allows for dimerization in solution but causes abnormal subcellular localization. Diabetes 47: 985-990
47. 47. Navas MA, Munoz-Elias EJ, Kim J, Shih D, Stoffel M (1999) Functional characterization of the MODY1 gene mutations HNF4(R127W), HNF4 (V255M), and HNF4(E276Q). Diabetes 48: 1459-1465
48. 48. Hayashi K, Yandell DW (1993) How sensitive is PCRSSCP? Hum Mutat 2: 338-346